69542-93-4(Pivagabine)
Product Description
69542-93-4
CAS No.
69542-93-4
Chemical Name:
Pivagabine
CBNumber:
CB2928582
Molecular Formula:
C9H17NO3
Formula Weight:
187.24
MOL File:
Mol file
Pivagabine Synonyms:
4-[(2,2-dimethylpropionyl)amino]butyric acid
4-(Pivaloylamino)butanoic acid
4-PivalaMidobutanoic acid
CXB 722
PG 2 (pharmaceutical)
Tonerg
Butanoic acid,4-[(2,2-diMethyl-1-oxopropyl)aMino]-
Pivagabine
Pivagabine
Property
Boiling point:
397.0±25.0 °C(Predicted)
Density
1.053±0.06 g/cm3(Predicted)
storage temp.
Sealed in dry,Room Temperature
solubility
Soluble in DMSO
pka
4.66±0.10(Predicted)
form
Solid
color
White to off-white
Safety
Pivagabine
Suppliers
Global( 34)Suppliers
China 24
India 1
Ukraine 3
United Kingdom 2
United States 4
Global 34
Supplier
Tel
Email
Country
ProdList
Advantage
TargetMol Chemicals Inc.
marketing@tsbiochem.com
China
18779
58
Shanghai Yanbang Pharmaceutical Technology Co., Ltd
1228181347@qq.com
China
8117
58
Shanghai Haohong Pharmaceutical Co., Ltd.
400-8210725
malulu@leyan.com
China
40037
58
Zhengzhou Guancheng Laboratory equipment Sales
0371-88888888
2723695949@qq.com
China
4874
50
RD International Technology Co., Limited
market@ubiochem.com
China
9268
58
Chengdu Jiuding Chemical Technology Co., Ltd. - Song Bo
312074905@qq.com
China
2508
58
Jining Yize Pharmaceutical Technology Co., Ltd
15192473210
302633902@qq.com
China
4482
58
Shanghai?Medlife?Pharm-Tech?Co.,?Ltd
021-59167510
vip@med-life.cn
China
5012
58
69542-93-4(Pivagabine)
Related Search:
4-[(2,2-dimethylpropionyl)amino]butyric acid
4-(Pivaloylamino)butanoic acid
4-PivalaMidobutanoic acid
CXB 722
PG 2 (pharmaceutical)
Tonerg
Butanoic acid,4-[(2,2-diMethyl-1-oxopropyl)aMino]-
Pivagabine
N-trimethylacetyl-4-aminobutyric acid
4-(2,2-Dimethylpropionamido)butanoic acid
Pivagabine,blood-brain,γ-Aminobutyric acid Receptor,psychoactive,CXB722,derivative,Inhibitor,inhibit,foot,factor,barrier,CXB 722,shock,Gamma-aminobutyric acid Receptor,GABA Receptor,neuromodulatory,corticotropin-releasing
69542-93-4
Copyright 2017 © ChemicalBook. All rights reserved